Osteopontin increases the proliferation of neural progenitor cells

International Journal of Developmental Neuroscience

Volumn 30, Issue 5, 2012, Pages 359-362

  Kalluri, Haviryaji S G ^a   Dempsey, Robert J ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Cardiovascular Research Center   (United States)

Author keywords

Akt; Cell cycle; Osteopontin; Proliferation; Survival

Indexed keywords

BROXURIDINE; CYCLIN D1; FIBROBLAST GROWTH FACTOR 2; OSTEOPONTIN; PROTEIN KINASE B; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INDUCTION; IMMUNOBLOTTING; IN VITRO STUDY; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION;

ANIMALS; BRAIN; BROMODEOXYURIDINE; CDC2 PROTEIN KINASE; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; NEURAL STEM CELLS; OSTEOPONTIN; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED SHR; RETINOBLASTOMA PROTEIN;

EID: 84862163735     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2012.04.003     Document Type: Article

References (34)

1. Angelucci A., Festuccia C., Gravina G.L., Muzi P., Bonghi L., Vicentini C., Bologna M. Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells. Prostate 2004, 59(2):157-166.
2. Caers J., Gunthert H., De Raeve H., Van Valckendorgh E., Menu E., Van Riet I., Van Camp B., Vanderkerken K. The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM model. British Journal of Haematology 2005, 132:469-477.
3. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 2002, 296:1655-1657.
4. Connell-Crowley L., Harper J.W., Goodrich D.W. Cyclin D1/CDK4 regulates retinoblastoma protein-mediated cell-cycle arrest by site-specific phosphorylation. Molecular Biology of the Cell 1997, 8:287-301.
5. Das R., Philip S., Mahabeleshwar G.H., Bulbule A., Kundu G.C. Osteopontin: its role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression. IUBMB 2005, 57(6):441-447.
6. Diehl J.A., Cheng M., Roussel M.F., Sherr C.J. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes and Development 1998, 12:3499-3511.
7. Ding Q., Stewart J., Prince C.W., Chang P.L., Trikha M., Han X., Grammer J.R., Gladson C.L. Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin. Cancer Research 2002, 62:5336-5343.
8. Doyle K.P., Yang T., Lessov N.S., Ciesielski T.M., Stevens S.L., Simon R.P., King J.S., Stenzel-Poore M.P. Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke. Journal of Cerebral Blood Flow and Metabolism 2008, 28(6):125-1248.
9. Fong Y.C., Liu S.C., Huang C.Y., Li T.M., Hsu S.F., Kao S.T., Tsai F.J., Chen W.C., Chen C.Y., Tang C.H. Osteopontin increases lung cancer cells migration via activation of alphabeta3 integrin/FAK/Akt and NF-kappa B dependent pathway. Lung Cancer 2009, 64(3):263-270.
10. Frederick T.J., Wood T.L. IGF-I and FGF2 coordinately enhance cyclin D1 and cyclin E-CDK2 association and activity to promote G1 progression in oligodendrocyte progenitor cells. Molecular and Cellular Neurosciences 2004, 25:480-492.
11. Frederick T.J., Min J., Altieri S.C., Mitchell N.E., Wood T.L. Synergistic induction of cyclin D1 in oligodendrocyte progenitor cells by IGF-1 and FGF-2 requires differential stimulation of multiple signaling pathways. Glia 2007, 55(10):1011-1022.
12. Gardner H.A., Berse B., Senger D.R. Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. Oncogene 1994, 9(8):2321-2326.
13. Giachelli C.M., Liaw L., Murry C.E., Schwartz Z.M., Almeida M. Osteopontin expression in cardiovascular diseases. Annals of the New York Academy of Sciences 1995, 760:109-126.
14. Issa R., AlQteishat A., Mitsios N., Saka M., Krupinski J., Tarkowski E., Gaffney J., Slevin M., Kumar S., Kumar P. Expression of basic fibroblast growth factor mRNA and protein in the human brain following ischemic stroke. Angiogenesis 2005, 8(1):53-62.
15. Kalluri H., Vemuganti R., Dempsey R.J. Lack of response to epidermal growth factor in adult neural progenitor cells. Neuroreport 2005, 16(8):835-838.
16. Kalluri H., Vemuganti R., Dempsey R.J. Mechanism of insulin like growth factor I mediated proliferation of adult neural progenitor cells: role of Akt. The European Journal of Neuroscience 2007, 25:1041-1048.
17. Kalluri H., Dempsey R.J. IGFBP-3 inhibits the proliferation of neural progenitor cells. Neurochemical Research 2011, 36(3):406-411.
18. Lee C.C., Huang C.C., Hsu K.S. Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways. Neuropharmacology 2011, 61(4):867-869.
19. Lin Y.H., Yang-Yen H.F. The osteopontin-CD44 survival signal involves activation of the phosphoatidylinositol 3-kinase/Akt signaling pathway. Journal of Biological Chemistry 2001, 276(49):46024-46030.
20. Lundberg A.S., Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-CDK complexes. Molecular and Cellular Biology 1998, 18:753-761.
21. Luo X., Ruhland M.K., Pazolli E., Lind A.C., Stewart S. Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway. Molecular Cancer Research June 2011, (Epub ahead of print).
22. Matsumura M., Suzuki T., Suzuki M., Tanaka R., Ito E., Saito T. Statin mediated reduction of osteopontin expression induces apoptois and cell growth arrest in ovarian clear cell carcinoma. Oncology Reports 2011, 25(1):41-47.
23. Matusan-Ilijas K., Behrem S., Jonjic N., Zarkovic K., Lucin K. Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma. Pathology Oncology Research 2008, 14:293-298.
24. Ogata T., Ueyama T., Nomura T., Asada S., Tagawa M., Nakamura T., Takahashi T., Matsubata H., Oh H. Osteopontin is myosphere-derived secretory molecule that promotes angiogenic progenitor cell proliferation through the phosphoinositide-3 kinase/Akt pathway. Biochemical and Biophysical Research Communications 2007, 359(2):341-347.
25. Parrales A., Lopez E., Lopez-Colome A.M. Thrombin activation of PI3K/PDJ1/Akt signaling promotes cyclin D1 upregualtion and RPE cell proliferation. Biochimica et Biophysica Acta June 2011, (Epub ahead of print).
26. Sailor K.A., Dhodda V.K., Rao V.L., Dempsey R.J. Osteopontininfusion into normal adult rat brain fails to increase cell proliferation in dentate gyrus and subventricular zone. Acta Neurochirurgica 2003, Suppl. 86:181-185.
27. Speliots E.K., Caday C.G., Do T., Weise J., Kowall N.W., Finklestein S.P. Increased expression of basic fibroblast growth factor (bFGF) following focal cerebral infarction in the rat. Brain Research. Molecular Brain Research 1996, 39(1-2):31-42.
28. Van Velthoven C.T., Heijnen C.J., van Bel F., Kavelaars A. Osteopontin enhances endogenous repair after neonatal hypoxic-ischemic brain injury. Stroke 2011, 42:2294-2301.
29. Wachs F.P., Couillard-Despres S., Engelhardt M., Wilhelm D., Ploetz S., Vroemen M., Kaesbauer J., Uyanik G., Klucken J., Karl C., Tebbing J., Svendsen C., Weidner N., Kuhn H.G., Winkler J., Aigner L. High efficacy of clonal growth and expansion of adult neural stem cells. Laboratory Investigation 2003, 83(7):949-962.
30. Wang X., louden C., Yue T.L., Ellison J.A., Barone F.C., Solleveld H.A., Feuerstein G.Z. Delayed expression of osteopontin after focal stroke in the rat. Journal of Neuroscience 1998, 18:2075-2083.
31. Wang Y., Yan W., Lu X., Qian C., Zhang J., Li P., Shi L., Zhao P., Fu Z., Pu P., Kang C., Jiang T., Liu N., You Y. Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avb3/PI3K/Akt/eNOS/NO signaling pathway in glioma cells. European Journal of Cell Biology 2011, 90(8):642-648.
32. Wu C.L., Zukerberg L.R., Ngwu C., Harlow E., Lees J.A. In vivo association of E2F and DP family proteins. Molecular and Cellular Biology 1995, 15(5):2536-2546.
33. Yan Y.P., Lang B.T., Vemuganti R., Dempsey R.J. Osteopontin is a mediator of the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia. Neurochemistry International 2009, 55(8):826-832.
34. Zhao B., Sun T., Meng F., Qu A., Li C., Shen H., Jin Y., Li W. Osteopontin as a potential biomarker of proliferation and invasiveness for lung cancer. Journal of Cancer Research and Clinical Oncology 2011, 137(7):1061-1070.